Fundraising FoxBritish Patient Capital
Government fundLondon · Series A–Growth
Find your way into British Patient Capital
Sign up to see every warm intro you have to British Patient Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the British Patient Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
What they invest in
from 15 of 17 portfolio companiesAI & Machine Learning ×7Biotech ×5Deep Tech ×5Digital Health ×5Healthtech ×5SaaS ×5Enterprise Software ×4Medical Devices ×4
HQs:United Kingdom×8China×1United States×1
Investments · 17 tracked
founders shown can be your intro pathBy year:2024 · 32023 · 22022 · 32021 · 12020 · 12017 · 111 dated
Pragmatic is a European semiconductor company developing clean chips designed to reduce carbon emissions and waste compared to silicon alternatives.
CleantechDeep TechHardwareSemiconductorsCambridge, GB
Co-investorsCambridge Innovation CapitalIn-Q-TelProsperity7 VenturesARMCatalystNorth East Development Capital Fund+4 more
TOM VIP邮箱 provides a paid email service for individuals and businesses, offering SSL-encrypted email, a dedicated VIP channel, and mobile email management integrated with WeChat.
Enterprise SoftwareSaaS
Co-investorsCathay Capital
Accurx builds a communication platform that connects patients with healthcare professionals, supporting tasks like appointment booking, patient contact, referrals, video consultations, and health surveys.
Digital HealthHealthtechSaaSLondon, GB
Jacob Haddad(Founder)inLaurence Bargery(Founder)in
Co-investorsBeyond CapitalEntrepreneur FirstLocalGlobeMoonfire VenturesTranspose Platform ManagementAtomico+1 more
Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.
AI & Machine LearningBiotechDeep TechHealthtech
Jane Osbourn(Founder)Young Kwon(Founder)
Co-investorsRA CapitalSV Health InvestorsDCVC BioDementia Discovery FundLightstone VenturesOno Venture Investment, Inc.+3 more
Cambridge GaN Devices is a fabless semiconductor company that develops energy-efficient GaN-based power devices for sustainable electronics.
CleantechDeep TechEnergyHardwareSemiconductorsCambridge, GB
Fabio Necco(CEO)in
Co-investorsCambridge Innovation CapitalEMV CapitalIQ CapitalMartlet CapitalBusiness Growth FundePlanet Capital+1 more
.jpeg){kind=logo}
CloudNC develops CAM Assist, software for machine shops that automates programming, quoting, and tool selection to reduce manual work and increase productivity.
Advanced ManufacturingAI & Machine LearningEnterprise SoftwareSaaSLondon, GB
Theo Saville(CEO & Co-Founder)inChris Emery(Chief Scientist & Co-Founder)in
Co-investorsAdelineAtomicoBackedBootstrap EuropeCelero Ventures Ltd.Entrepreneur First+8 more
VC fund (founded 2006) supporting entrepreneurs with investment capital and experience.
Co-investorsEnBW New Ventures GmbHKfW CapitalTesi (Finnish Industry Investment Ltd)European Investment Fund
Greywolf is a clinical-stage biotech developing antigen modulation therapies, including oral small molecules in Phase 1/2 trials, for people with cancers and autoimmune disorders.
BiotechDigital HealthHealthtechMedical DevicesOxford, GB
Peter Joyce(Co-founder)inTom McCarthy(Co-founder)in
Co-investorsAndera PartnersCanaan PartnersOxford Science EnterprisesPfizer Venture InvestmentsEarlybird Venture CapitalPfizer Ventures
Hoxton Ventures is a venture capital firm that invests in AI and deeptech startups across the UK and Europe, providing capital, compute access, and infrastructure support to founders building transformative companies.
AI & Machine LearningDeep TechSector AgnosticLondon, GB
Hussein Kanji(Founder and Managing Partner)in
Co-investorsAMK Investment OfficeBeast VenturesCisco InvestmentsIsomer CapitalBritish Business Bank
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsJJDCPfizer Ventures
Oxx is a venture capital firm that invests in European B2B software and SaaS companies at the scale-up stage, typically Series A or B after product-market fit.
Enterprise SoftwareFintechSaaS
Mikael Johnsson(Co-founder)inRichard Anton(Co-founder)
Co-investorsKfW CapitalLeo Capital VenturesCapital One VenturesOurCrowd
Oyster Bay is a venture capital firm that invests in impact-driven companies across the food value chain, from agriculture and food-service robotics to alternative ingredients and food brands.
AgTechFoodTechImpact & Social Good
Co-investorsKfW CapitalCapital One VenturesOurCrowdOxx
Perspectum develops digital medical technology and diagnostics using multiparametric MRI to assess and diagnose chronic systemic diseases including liver disease, long COVID, diabetes, and cancer for clinicians and patients.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesOxford, GB
Rajarshi Banerjee(CEO)in
Co-investorsBlue Venture FundsOxford Science EnterprisesHealthQuest CapitalSandbox Industries
Proximie provides a cloud-based operating system for connected operating rooms, giving medtech companies and hospitals real-time OR connectivity, structured surgical data, and AI-driven insights.
AI & Machine LearningDigital HealthMedical DevicesSaaSAltrincham
Nadine Hachach-Haram(Founder)inJonathan Lim(Director)inScott Huennekens(Director)in
BoardMohammed Shahzad Ahmed Malik(Director)
Co-investorsAdvent Life SciencesCapria VenturesCedar Mundi VenturesCOTU VenturesDraper AssociatesF-Prime Capital+6 more
Purespring develops genetic therapies targeting podocytes to treat renal diseases through its proprietary GlomThera platform.
BiotechDigital HealthHealthtechMedical Devices
Moin Saleem(Co-founder & Chief Scientific Advisor)in
Co-investorsSofinnova PartnersForbionGilde HealthcareAdvent Life Sciences
Quantexa is a data, analytics, and AI platform that provides Contextual Decision Intelligence by unifying fragmented data into a connected view and using advanced analytics and explainable AI to uncover hidden patterns and relationships.
AI & Machine LearningData & InfrastructureEnterprise SoftwareLondon, GB
Vishal Marria(Founder)inAlexon Bell(Founder)Felix Hoddinott(Founder)Imam Hoque(Founder)Jamie Hutton(Founder)Laura Hutton(Founder)
Co-investorsAlbion Capital GroupAlbionVCDawn CapitalEvolution Equity PartnersTeachers' Venture GrowthWarburg Pincus+2 more
Portfolio news
latest coverage across their companiesQuantexa · en.wikipedia.org · Aug 27, 2026
Alchemab · trysignalbase.com · Jul 10, 2026
Purespring · purespringtx.com · Oct 4, 2025
Principals & officers · per Companies House
what is this? ⓘSecretary · since 2023
Director · British · since 2025
Director · British · since 2025
Director · British · since 2022
Bbb Investment Holdings Limited — 75–100% of shares, 75–100% of voting rights, right to appoint and remove directors
Frequently asked questions
- How many investments has British Patient Capital made?
- British Patient Capital has 17 tracked investments.
- What stage does British Patient Capital invest at?
- British Patient Capital invests at the Series A, Series B, Series C, Growth stages.
- What sectors does British Patient Capital focus on?
- British Patient Capital focuses on Sector Agnostic.
- Where is British Patient Capital located?
- British Patient Capital is headquartered in London, GB.
Similar investors
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.
AirTree Ventures runs Pathfinders, a free four-week in-person program in Sydney for young builders (high-school graduates up to age 23) to work on a real product, access the AirTree team and founders, and build a peer network.
Andreessen Horowitz (a16z) is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz, known for pioneering the platform model with a large team of operators supporting founders across stages.
Atomico is an international venture capital firm that invests in growth-stage technology companies across multiple geographies. The firm focuses on scaling disruptive technology businesses globally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.